Seasoned engineers and people with zero coding experience are embracing "vibe coding" — the act of relying on AI to write ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports.

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by analysts at Barclays from $435.00 to $467.00 in a research report issued to clients and investors on ...

Three new directors have been appointed to the Riot Platforms board, bringing experience in shifting Bitcoin mining assets to ...

Contract lifecycle management firm SpotDraft, which is backed by marquee investors such as Wipro founder-chairman Azim ...

Fintel reports that on February 12, 2025, Canaccord Genuity upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

U.S. stocks started lower on Tuesday as investors await Fed Chair Powell's remarks about the economy, tariffs, inflation and more.

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...